Kabir A. Khan

1.6k citations
21 papers · 1.2k indexed · 2 hit papers · h-index 15
Topics
Angiogenesis and VEGF in Cancer (11 papers)Cell Adhesion Molecules Research (6 papers)Protease and Inhibitor Mechanisms (3 papers)

In The Last Decade

Kabir A. Khan

21 papers receiving 1.2k citations

Hit Papers

Improving immunotherapy outcomes with anti-angiogenic tre...201820262020202320182024100200300400

Peers

Kabir A. Khan
Comparison fields: 5 of 91
  • Molecular Biology 547
  • Oncology 489
  • Immunology 320
  • Cancer Research 217
  • Pulmonary and Respiratory Medicine 199
Replace Hiroki Hashida with:
Hiroki Hashida Japan
Dakeun Lee South Korea
Kenji Shibuta Japan
Lee B. Rivera United States
Beryl Y. Eve United States
Yvonne T.M. Tsang United States
Amy Ziober United States
Philippe Pujuguet Belgium
A. Reza Radjabi United States
Shinobu Iwai Japan
Kabir A. Khan relative to Hiroki Hashida Japan Hiroki Hashida's profile →
Citations per field
00.5×1.5×2.5×
Hiroki Hashida · 1×
Citations per year

Countries citing papers authored by Kabir A. Khan

Since Specialization
Citations

This map shows the geographic impact of Kabir A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kabir A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kabir A. Khan more than expected).

Fields of papers citing papers by Kabir A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kabir A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kabir A. Khan. The network helps show where Kabir A. Khan may publish in the future.

Co-authorship network of co-authors of Kabir A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Kabir A. Khan. A scholar is included among the top collaborators of Kabir A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kabir A. Khan. Kabir A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trialsbreakdown →
47
2 1
3 41
4 28
5 7
6 61
7
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versabreakdown →
479
8 39
9 23
10 55
11 29
12 43
13 24
14 121
15 3
16 60
17 72
18
Thoracic and Chest Pain
2
19
Extracolonic findings at CT colonography an a symptomatic population (oral abstract)
1
20
Hemangiopericytoma of greater omentum.
9

About Kabir A. Khan

Kabir A. Khan is a scholar working on Immunology and Allergy, Cancer Research and Immunology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Cell Adhesion Molecules Research (6 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Immunology and Allergy (163 citations), Oncology (489 citations) and Immunology (320 citations). Kabir A. Khan has collaborated with scholars based in United Kingdom, Canada and India. Frequent co-authors include Robert S. Kerbel, Roy Bicknell, Michael G. Tomlinson, Fiyaz Mohammed, Peter J. Noy, Jon Frampton, Martyn Chidgey, Paloma García, Jing Yang and Schickwann Tsai. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026